Who invested in BioAxone Therapeutic?
BioAxone Therapeutic's investors include Desjardins Venture Capital, Fonds de solidarite Ftq, T2C2 Capital and Lothian Partners.
Canada · Series B startup
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$12Mraised across 1 round since 2005, from 1 source
Reported by biospace.com
BioAxone Therapeutic's investors include Desjardins Venture Capital, Fonds de solidarite Ftq, T2C2 Capital and Lothian Partners.
BioAxone Therapeutic has raised $12M across 1 round since 2005.
BioAxone Therapeutic's most recent round was a Series B of $12M in May 2005.
Its most recent round, $12M in May 2005, is also its largest on record.
BioAxone Therapeutic's first round on record, in May 2005, was backed by Desjardins Venture Capital, Fonds de solidarite Ftq and T2C2 Capital and 1 others.
BioAxone Therapeutic's latest named round is a Series B, in May 2005.
BioAxone Therapeutic is based in Canada.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.